- Home
- MWA vs BLDEW Comparison
MWA vs BLDEW Comparison
Compare MWA & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MWA
- BLDEW
- Stock Information
- Founded
- MWA 1857
- BLDEW N/A
- Country
- MWA United States
- BLDEW United States
- Employees
- MWA N/A
- BLDEW 281
- Industry
- MWA Metal Fabrications
- BLDEW Transportation Services
- Sector
- MWA Industrials
- BLDEW Consumer Discretionary
- Exchange
- MWA Nasdaq
- BLDEW Nasdaq
- Market Cap
- MWA N/A
- BLDEW N/A
- IPO Year
- MWA 2006
- BLDEW 2019
- Fundamental
- Price
- MWA $22.94
- BLDEW $0.39
- Analyst Decision
- MWA Hold
- BLDEW
- Analyst Count
- MWA 5
- BLDEW 0
- Target Price
- MWA $22.20
- BLDEW N/A
- AVG Volume (30 Days)
- MWA 1.1M
- BLDEW N/A
- Earning Date
- MWA 02-06-2025
- BLDEW N/A
- Dividend Yield
- MWA 1.17%
- BLDEW N/A
- EPS Growth
- MWA 35.28
- BLDEW N/A
- EPS
- MWA 0.74
- BLDEW N/A
- Revenue
- MWA $1,314,700,000.00
- BLDEW N/A
- Revenue This Year
- MWA $4.13
- BLDEW N/A
- Revenue Next Year
- MWA $5.41
- BLDEW N/A
- P/E Ratio
- MWA $31.00
- BLDEW N/A
- Revenue Growth
- MWA 3.06
- BLDEW N/A
- 52 Week Low
- MWA $13.49
- BLDEW N/A
- 52 Week High
- MWA $26.28
- BLDEW N/A
- Technical
- Relative Strength Index (RSI)
- MWA 33.88
- BLDEW N/A
- Support Level
- MWA $24.08
- BLDEW N/A
- Resistance Level
- MWA $24.59
- BLDEW N/A
- Average True Range (ATR)
- MWA 0.54
- BLDEW 0.00
- MACD
- MWA -0.34
- BLDEW 0.00
- Stochastic Oscillator
- MWA 12.42
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.